Relatively increased number of liver Foxp³⁺ regulatory T cells against hepatic lesions in murine lupus

Abstract

Systemic lupus erythematosus (SLE) is a multiple organ autoimmune disorder, including the liver, but the possible reason in impairment in the liver is still unclear. Our present study assessed alterations of transcription factor Foxp3⁺ regulatory T cells (Tregs) and several other immune molecules [programmed cell death 1 and its ligand (PD1 and PD-L1), and interleukin 10 (IL-10) and transform growth factor β (TGF-β)] in the liver and other major organs of lupus-prone BXSB mice by flow cytometry, real-time quantitative reverse transcription PCR, and enzyme-linked immunosorbent assay. Results showed that both frequency and number of Foxp3⁺ Tregs were dramatically reduced in the thymus, spleen and kidney of the BXSB mice (P<0.05), but those in the liver were kept in nearly normal range, when compared to negative control C57BL/6 mice. In comparison to control mice, the mRNA levels of Foxp3, PD1 and PD-L1 were significantly decreased in the kidneys of BXSB mice (P<0.05), but there was no significant difference in the livers of the BXSB mice (P>0.05). Protein levels of IL-10 and TGF-β in serum showed no significant difference between BXSB and C57BL/6 mice, but were significantly increased in the kidneys and livers of BXSB mice as compared with those in C57BL/6 mice (P<0.05). These results suggest that reduced Foxp3⁺ Tregs are involved in the pathogenesis of SLE in BXSB mice, and relatively higher number of these cells in the livers than in the other target organs could constitute a protective mechanism against hepatic lesions in lupus-prone mice, which may provide insights into development of new therapeutic approaches in SLE patients.

Keywords

Foxp3 / hepatic lesion / lupus / BXSB mice

References

[1] CrispinJ.C., LiossisS.N., Kis-TothK., et al.. Pathogenesis of human systemic lupus erythematosus: recent advances. Trends Mol Med, 2010, 16(2): 47-57

[2] ShlomchikM.J., CraftJ.E., MamulaM.J.. From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol, 2001, 1(2): 147-153

[3] ChowdharyV.R., CrowsonC.S., PoteruchaJ.J., et al.. Liver involvement in systemic lupus erythematosus: case review of 40 patients. J Rheumatol, 2008, 35(11): 2159-2164

[4] YoussefW.I., TavillA.S.. Connective tissue diseases and the liver. J Clin Gastroenterol, 2002, 35(4): 345-349

[5] AbeJ., UehaS., SuzukiJ., et al.. Increased Foxp3(+) CD4(+) regulatory T cells with intact suppressive activity but altered cellular localization in murine lupus. Am J Pathol, 2008, 173(6): 1682-1692

[6] KuhnA., BeissertS., KrammerP.H.. CD4(+)CD25(+) regulatory T cells in human lupus erythematosus. Arch Dermatol Res, 2009, 301(1): 71-81

[7] ValenciaX., LipskyP.E.. CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases. Nat Clin Pract Rheumatol, 2007, 3(11): 619-626

[8] SakaguchiS.. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol, 2004, 22(1): 531-562

[9] CrispinJ.C., VargasM.I., Alcocer-VarelaJ.. Immunoregulatory T cells in autoimmunity. Autoimmun Rev, 2004, 3(2): 45-51

[10] FontenotJ.D., RasmussenJ.P., WilliamsL.M., et al.. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity, 2005, 22(3): 329-341

[11] WeiH.X., ChuangY.H., LiB., et al.. CD4+ CD25+ Foxp³⁺ regulatory T cells protect against T cell-mediated fulminant hepatitis in a TGF-beta-dependent manner in mice. J Immunol, 2008, 181(10): 7221-7229

[12] HerbertD.R., OrekovT., PerkinsC., et al.. IL-10 and TGF-beta redundantly protect against severe liver injury and mortality during acute schistosomiasis. J Immunol, 2008, 181(10): 7214-7220

[13] IzuiS., IwamotoM., FossatiL., et al.. The Yaa gene model of systemic lupus erythematosus. Immunol Rev, 1995, 144(1): 137-156

[14] RogersN.J., GabrielL., NunesC.T., et al.. Monocytosis in BXSB mice is due to epistasis between Yaa and the telomeric region of chromosome 1 but does not drive the disease process. Genes Immun, 2007, 8(8): 619-627

[15] ShevachE.M.. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol, 2002, 2(6): 389-400

[16] StephensL.A., BarclayA.N., MasonD.. Phenotypic characterization of regulatory CD4+CD25+ T cells in rats. Int Immunol, 2004, 16(2): 365-375

[17] PistinerM., WallaceD.J., NessimS., et al.. Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum, 1991, 21(1): 55-64

[18] AndrewsB.S., EisenbergR.A., TheofilopoulosA.N., et al.. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med, 1978, 148(5): 1198-1215

[19] ListonA., RudenskyA.Y.. Thymic development and peripheral homeostasis of regulatory T cells. Curr Opin Immunol, 2007, 19(2): 176-185

[20] HoriS., NomuraT., SakaguchiS.. Control of regulatory T cell development by the transcription factor Foxp3. Science, 2003, 299(5609): 1057-1061

[21] YamagiwaS., GrayJ.D., HashimotoS., et al.. A role for TGF-beta in the generation and expansion of CD4+ CD25+ regulatory T cells from human peripheral blood. J Immunol, 2001, 166(12): 7282-7289

[22] ChenW., JinW., HardegenN., et al.. Conversion of peripheral CD4+CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med, 2003, 198(12): 1875-1886

[23] WuH.Y., StainesN.A.. A deficiency of CD4+CD25+ T cells permits the development of spontaneous lupus-like disease in mice, and can be reversed by induction of mucosal tolerance to histone peptide autoantigen. Lupus, 2004, 13(3): 192-200

[24] HsuW.T., SuenJ.L., ChiangB.L.. The role of CD4CD25 T cells in autoantibody production in murine lupus. Clin Exp Immunol, 2006, 145(3): 513-519

[25] ZieglerS.F.. FOXP3: of mice and men. Annu Rev Immunol, 2006, 24(1): 209-226

[26] CarambiaA., HerkelJ.. CD4 T cells in hepatic immune tolerance. J Autoimmun, 2009, 34(1): 23-28

[27] KnolleP., SchlaakJ., UhrigA., et al.. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J Hepatol, 1995, 22(2): 226-229

[28] LuthS., HuberS., SchrammC., et al.. Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs. J Clin Invest, 2008, 118(10): 3403-3410

[29] NishimuraH., NoseM., HiaiH., et al.. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity, 1999, 11(2): 141-151

[30] OkazakiT., TanakaY., NishioR., et al.. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat Med, 2003, 9(12): 1477-1483

[31] KeirM.E., ButteM.J., FreemanG.J., et al.. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol, 2008, 26(1): 677-704

[32] OkazakiT., HonjoT.. PD-1 and PD-1 ligands: from discovery to clinical application. Int Immunol, 2007, 19(7): 813-824